Massachusetts' life sciences and startup ecosystem is facing a funding pullback, with venture capital share and the number of funded companies both declining in 2026.
Population loss, corporate relocations, and strain across education, health care, and biotech are fueling a debate over whether the Bay State's economic foundation is cracking.
